Clinical trial NCT01111201: International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients
Official title: Pilot Survey to Assess International Travel Patterns and Risk Behaviour of Breast Cancer, Lymphoma Patients and Bone Marrow Transplant Recipients at Memorial Sloan-Kettering Cancer Center
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: Breast Cancer
Lymphoma
Keywords: Autologous Bone Marrow Transplant
Breast
Lymphoma
International travel
questionnaire
Hematopoietic Stem Cell Transplant (HSCT) recipients
Lead sponsor: Memorial Sloan Kettering Cancer Center
Sponsor class: OTHER
First posted: 2010-04-27
Enrollment: 26
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: RETROSPECTIVE
Sampling method: NON_PROBABILITY_SAMPLE
Study population: The goal accrual is 50 patients from each of the following oncology services:

Breast, Lymphoma, Autologous Stem Cell Transplant, and Allogeneic Stem Cell Transplant.

Brief summary: This study also aims to raise awareness among both patients and health-care providers about the importance of pre-travel health consultation and preventive interventions prior to international travel.

Through appropriate health counseling, cancer patients will have less risk of having travel -related health complications and thus have a better quality of life and overall improved sense of wellbeing.


Eligibility criteria: Inclusion Criteria:

* Hematopoietic Stem Cell Transplant (HSCT) recipients
* Age \>18 years
* Status post bone marrow transplant within last five years Breast Cancer patients: Criteria 1 and Criteria 2 and/or 3
* Female age \>18 years and current or past history of breast cancer
* Received systemic chemotherapy in the last five years
* Metastatic breast cancer disease (stage IV) Lymphoma: Criteria 1 and Criteria 2 and/or 3
* Age \>18 years and current or past history of lymphoma
* Received systemic chemotherapy within 5 years
* Had active disease at any time within the last 5 years

Exclusion Criteria:

* Patients age\< 18 years
* Breast cancer and lymphoma patients in clinical remission in the past 5 years
* Patients unable to fill the questionnaire due to language barriers

Primary outcomes:
measure: To determine the frequency of international travel of the targeted patients in the last 5 years.
timeFrame: once at the time of the clinic visit
Secondary outcomes:
measure: To determine if any of the international travel was during a high-risk specific period when the immune status of the target population was compromised.
timeFrame: once at the time of the clinic visit
measure: To profile the target population who traveled internationally with respect to their demographic and cancer/transplant-related characteristics.
timeFrame: once at the time of the clinic visit
measure: To obtain detailed information about their last international trip including
timeFrame: once at the time of the clinic visit
measure: To assess the adequacy of the questionnaire instructions
timeFrame: once at the time of the clinic visit
Other outcomes:
Locations:
city: New York
country: United States
facility: Memorial Sloan Kettering Cancer Center
state: New York
Study officials:
affiliation: Memorial Sloan Kettering Cancer Center
name: Monika Shah, MD
role: PRINCIPAL_INVESTIGATOR
References: